PMHH has received necessary approvals from authorities for the recommended offer for Swedish Match and reminds the shareholders of the terms of the offer and of certain U.S. regulatory requirements

 

More Precise Diagnoses, Efficient Monitoring and Comfortable Patient Experiences are Hallmarks of Advanced Medical Technologies in the New HealthAlliance Hospital

 

European AI Startup Axelera AI Closes $27 Million Series A

 

Micreos’ Alternative to Antibiotics Secures Next €25 Million

 

The Karolinska Institutet’s Academic Specialist Center (ASC) to Present Results of GeNeuro’s ProTEct-MS Phase 2 Study of Temelimab at ECTRIMS 2022

 

MotorK: Transaction in Own Shares

 

Wolters Kluwer ELM Solutions Announces Winners of Sixth Annual Legal Innovator Awards

 

Scenic Biotech Appoints Jens Würthner as Chief Medical Officer

 

NHOA: Mathilde Lheureux Takes the Lead of Free2move eSolutions as New CEO

 

QIAGEN N.V. to Release Results for Q3 2022 and Hold Webcast